IP Library Assignment 045500/0816
Patent Assignment
Reel/Frame 045500/0816

Confirmatory License

Recorded: 2018-03-02 Pages: 2
Assignor
CEDARS-SINAI MEDICAL CENTER
Executed: 2018-01-04
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Targeting Trastuzumab-Resistant HER2+ Breast Cancer with a HER3-Targeting Nanoparticle
Patent: 9,850,293 →
Application: 14/678,972 →
Publication: US 2016/0060316
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 12, 2016
From: MEDINA-KAUWE, LALI K.; SIMS, JESSICA; TAGUAIM, MICHAEL; HANSON, CHRIS
To: CEDARS-SINAI MEDICAL CENTER
Reel/Frame 037470/0078 →